Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study

March 20, 2024

View Press Release Corporate presentation Contact us
Previous